VOYA Investment Management
PMVP icon

VOYA Investment Management’s PMV Pharmaceuticals PMVP Stock Holding History

VOYA Investment Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,020
Closed -$23.8K – 2890
2024
Q1 		$23.8K Sell
14,020
-2,862
-17% -$5.34K ﹤0.01% 2777
2023
Q4 		$52.3K Hold
16,882
– – ﹤0.01% 2844
2023
Q3 		$104K Hold
16,882
– – ﹤0.01% 2722
2023
Q2 		$106K Buy
16,882
+2,157
+15% +$11.3K ﹤0.01% 2774
2023
Q1 		$70.2K Hold
14,725
– – ﹤0.01% 2752
2022
Q4 		$128K Hold
14,725
– – ﹤0.01% 2698
2022
Q3 		$175K Buy
14,725
+984
+7% +$14.2K ﹤0.01% 2642
2022
Q2 		$196K Buy
13,741
+3,432
+33% +$49.9K ﹤0.01% 2404
2022
Q1 		$215K Hold
10,309
– – ﹤0.01% 2330
2021
Q4 		$238K Buy
10,309
+31
+0.3% +$749 ﹤0.01% 2414
2021
Q3 		$306K Hold
10,278
– – ﹤0.01% 2341
2021
Q2 		$351K Buy
10,278
+3,983
+63% +$133K ﹤0.01% 2301
2021
Q1 		$207K Buy
6,295
+1,330
+27% +$52.4K ﹤0.01% 2525
2020
Q4 		$305K Buy
+4,965
New +$195K ﹤0.01% 2184

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

VOYA Investment Management's PMVP Position: Q2 2024 in Review

VOYA Investment Management sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 14,020 shares — an estimated $23.8K sold.

VOYA Investment Management first reported a position in PMVP in Q4 2020 and held it in 14 quarters. The position peaked at $351K in Q2 2021. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • VOYA Investment Management reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 14,020 PMV Pharmaceuticals shares in Q2 2024, an estimated $23.8K.
  • VOYA Investment Management first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • VOYA Investment Management's PMV Pharmaceuticals position peaked at $351K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.